Loss of response after first-line biologic therapy in patients with inflammatory bowel disease: practical approach and management

被引：0
|
作者：
Busacca, A. [1 ]
Scrivo, B. [1 ]
Giuffrida, E. [1 ]
Guida, L. [1 ]
Carrozza, L. [1 ]
Calvaruso, V. [1 ]
Cappello, M. [1 ]
机构：
[1] Univ Palermo, Gastroenterol & Hepatol Sect, PROMISE, Palermo, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P293
引用
收藏
页码：S299 / S299
页数：1
相关论文
共 50 条
  • [41] The role of intestinal ultrasound with colour Doppler in predicting the response to biologic therapy in inflammatory bowel disease patients
    El-Nady, Mohamed Ali
    El-Hefny, Nour Eldeen
    Fathy, Hayam
    Ali, Wageeh
    Ashmawy, Ahmed Mohammed
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2024, 19 (04): : 416 - 422
  • [42] Management of Inflammatory Bowel Disease in Pregnancy: A Practical Approach to New Guidelines
    Huang, V.
    Leung, Y.
    Nguyen, G. C.
    Seow, C. H.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 2016
  • [43] Management of iron deficiency anemia in inflammatory bowel disease - a practical approach
    Stein, Juergen
    Dignass, Axel U.
    ANNALS OF GASTROENTEROLOGY, 2013, 26 (02): : 104 - 113
  • [44] Failure of Vedolizumab as First-Line Biologic Does Not Decrease Response Rates of Second-Line Therapy
    Ritter, Timothy E.
    Fourment, Chris
    Okoro, Tracy C.
    Hardin, Thomas C.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S381 - S382
  • [45] EFFICACY AND DURABILITY OF BIOLOGIC THERAPY AFTER FAILURE OF INITIAL AND SUBSEQUENT BIOLOGIC AGENTS IN INFLAMMATORY BOWEL DISEASE
    Cusumano, Vivy T.
    Ebriani, Joseph
    Prakash, Preeti
    Dua, Anoushka
    Fansiwala, Kush
    Spartz, Ellen
    Sauk, Jenny S.
    Limketkai, Berkeley N.
    GASTROENTEROLOGY, 2022, 162 (07) : S816 - S816
  • [46] Predicting response to dose escalation in patients with inflammatory bowel disease with secondary loss of response to biological therapy
    Tambakis, G.
    Sebastian, T.
    Sun, G.
    Reynen, T.
    Van Wees, M.
    Bhoopal, A.
    Splatt, L.
    Cunningham, G.
    Shelton, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 111 - 111
  • [47] Changes in gut microbiota of patients with inflammatory bowel disease receiving biologic therapy
    Tai, W. C.
    Yao, C. C.
    Tsai, Y. -C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2153 - I2153
  • [48] VACCINATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY, ARE THEY BEING CONSIDERED?
    Chatten, K.
    Cornthwaite, L.
    Nixon, E.
    Goel, A.
    GUT, 2017, 66 : A243 - A244
  • [49] LOWER SUSTAINED PERTUSSIS CONCENTRATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGIC THERAPY
    Caldera, Freddy
    McCrone, Sue
    Garmoe, Christine A.
    Megna, Bryant W.
    Ley, Dana
    Reichelderfer, Mark
    Hayney, Mary S.
    GASTROENTEROLOGY, 2017, 152 (05) : S59 - S59
  • [50] Overuse of Tuberculosis Screening Practices in Patients With Inflammatory Bowel Disease on Biologic Therapy
    Vecchio, Eric
    Mao, Eric
    Fine, Sean
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S369 - S369
12345